NSCLC, STAGE IB-IIIA

Clinical trials for NSCLC, STAGE IB-IIIA explained in plain language.

Never miss a new study

Get alerted when new NSCLC, STAGE IB-IIIA trials appear

Sign up with your email to follow new studies for NSCLC, STAGE IB-IIIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope to stop lung Cancer's return after surgery

Disease control Recruiting now

This study is testing whether adding a new drug called zipalertinib to standard chemotherapy after lung cancer surgery works better than chemotherapy alone. It's for people with early-stage lung cancer who have specific, less common genetic changes in their tumor. The goal is to …

Matched conditions: NSCLC, STAGE IB-IIIA

Phase: PHASE3 • Sponsor: Taiho Oncology, Inc. • Aim: Disease control

Last updated Mar 30, 2026 14:35 UTC

NSCLC, STAGE IB-IIIA

Get alerted when new NSCLC, STAGE IB-IIIA trials appear

New hope to stop lung Cancer's return after surgery